Home » News » CROs/Service Providers » BioTrak Research launches Patient Recruiters International

BioTrak Research launches Patient Recruiters International

Tuesday, November 8, 2011

BioTrak Research, a contract research organization, has launched Patient Recruiters International, a full-service patient recruitment organization.

The launch of PRI is a direct response to the increasing demand for qualified research subjects in the clinical research field. With patient recruitment and retention as a critical part of successful clinical research, PRI accelerates the recruitment and enrollment process and reduces per-patient recruitment costs for sponsors through new and powerful direct-to-patient access solutions.
 
“We see the need for more creative and targeted patient recruitment strategies as the competition for research subjects continues to grow,” states Larry Risen, president of Patient Recruiters International. “PRI addresses this challenge by using large proprietary patient databases, online patient communities and social media to increase referrals for research studies.”
 
As a full-service patient recruitment services organization, PRI provides patient retention services as well as innovative recruitment solutions that combines direct patient access strategies with traditional media such as television, video, radio, and print advertising. PRI’s specialized data capabilities can reach over 120 million covered lives in the U.S. As part of this reach, PRI is launching GoHealthPanel.com, an online community of people with health conditions wanting to become involved in meaningful research.
 
“We understand the clinical research process” states Karl Cremer, PharmD, Senior Vice President, Clinical Affairs. “When the protocol is finalized, the patient population always seems to be smaller than when you started. PRI has the experience, strategies, and tools to find the right patients in an accelerated fashion.”
 
Previously operating as a unit of BioTrak, PRI has a 12-year history of recruiting subjects for over 300 research studies involving patients, pharmacists, and healthcare professionals.

Related Posts